[HTML][HTML] Poly (ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality

M Leung, D Rosen, S Fields, A Cesano, DR Budman - Molecular medicine, 2011 - Springer
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

[HTML][HTML] Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

M Leung, D Rosen, S Fields… - Molecular …, 2011 - molmed.biomedcentral.com
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

[PDF][PDF] Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

M Leung, D Rosen, S Fields, A Cesano, DR Budman - MOL MED, 2011 - academia.edu
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

Poly (ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality

M Leung, D Rosen, S Fields… - Molecular …, 2011 - pubmed.ncbi.nlm.nih.gov
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality.

M Leung, D Rosen, S Fields, A Cesano… - Molecular …, 2011 - search.ebscohost.com
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

Poly (ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality.

M Leung, D Rosen, S Fields, A Cesano… - Molecular Medicine …, 2011 - europepmc.org
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

[HTML][HTML] Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

M Leung, D Rosen, S Fields, A Cesano… - Molecular …, 2011 - ncbi.nlm.nih.gov
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

[引用][C] Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

M Leung, D Rosen, S Fields, A Cesano… - Molecular …, 2011 - cir.nii.ac.jp
Poly(ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic
Lethality | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

Poly (ADP-ribose) polymerase-1 inhibition: preclinical and clinical development of synthetic lethality.

M Leung, D Rosen, S Fields, A Cesano… - Molecular Medicine …, 2011 - europepmc.org
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …

[PDF][PDF] Poly (ADP-Ribose) Polymerase-1 Inhibition: Preclinical and Clinical Development of Synthetic Lethality

M Leung, D Rosen, S Fields, A Cesano… - MOL …, 2011 - molmed.biomedcentral.com
The hereditary forms of breast cancer identified by BRCA1 and BRCA2 genes have a defect
in homologous DNA repair and demonstrate a dependence on alternate DNA repair …